Contrave Weight Loss: Top OTC Contrave Weight Loss Medication Alternative From PhenQ
Contrave is taken to help people lose weight. It is a combination of two medicines that work in the brain...
Brain
Best Berberine Supplement: Top Berberine Supplements For Weight Loss & Blood Sugar From Sugar Defender
Best Berberine Supplement for Weight loss and Blood sugar. It is used for centuries in traditional medicine, berberine is now...
uniQure Announces FDA Breakthrough Therapy Designation Granted to AMT-130 for the Treatment of Huntington’s Disease
~ Breakthrough Therapy designation based on clinical evidence from Phase I/II trials showing meaningful slowing of disease progression ~ ~...
NeuroOne® Issues Letter to Shareholders
Company Now Fully Funded Through at least Fiscal 2026; Company Confirms No Material Impact from Global Tariffs EDEN PRAIRIE, Minn.,...
Epilepsy Foundation of America Launches Comprehensive Epilepsy & Seizure Safe Classrooms Toolkit for K-12 Educators
The Toolkit Fosters Safe and Inclusive Learning Environments for Students with EpilepsyBOWIE, Md., April 16, 2025 (GLOBE NEWSWIRE) -- The...
BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease with First Patient Enrolled
SUNRISE-PD evaluating the Company’s anti-inflammatory, insulin-sensitizing candidate bezisterim in patients with Parkinson’s disease who have not been treated with carbidopa/levodopa...
Best Appetite Suppressants – Natural Over the Counter (OTC) Appetite Suppressant for Hunger Control & Fat Burner ( Men & Women) – By Phenq CrazyBulk in USA
CrazyBulk CrazyBulk Albany, New York, April 16, 2025 (GLOBE NEWSWIRE) -- Struggling to control your appetite and cravings? You're not...
Oxford Scientists Reveal Sunlight-Powered Anti-Cancer Breakthrough
Scientists reveal GPDT (Green Products Photodynamic Technology) Oxperial BioHealth has revealed a major breakthrough in cancer prevention OXFORD, United Kingdom,...
AI, Neuromodulation & Thrombectomy Drive $7.6B Growth in U.S. Neurological Devices Market – New iData Research Report Forecasts $10B by 2030
VANCOUVER, BC, April 15, 2025 /PRNewswire/ - A new U.S. Neurological Devices Market Report provides essential insights for CEOs, CFOs, product...
Cadwell Makes a Strategic Investment in Seer Medical to Expand Home-Based Epilepsy Diagnostics
KENNEWICK, Wash., April 15, 2025 /PRNewswire/ -- Cadwell Industries, Inc., a global leader in neurodiagnostic, neuromonitoring, and sleep solutions, today...
Open nominations for the BIAL Award in Biomedicine 2025 with an increased amount to €350,000
Created to distinguish the most remarkable scientific discoveries in the biomedical field, this international award has been granted a growing reputation...
PreveCeutical Announces Up-Sized Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - April 14, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company"...
US Clinical Communication & Collaboration Market worth US$1.57 billion by 2029 with 13.5% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., April 14, 2025 /PRNewswire/ -- The US Clinical Communication & Collaboration Market is expected to reach US$1.57 billion by...
NeuroOne® OneRF® Technology Success Story Featured on Fox News
Pediatric Patient Treated with OneRF® Ablation System Goes From Up to 10 Nightly Seizures to Zero EDEN PRAIRIE, Minn., April...
MYndspan Appoints Holmusk Founder and CEO Nawal Roy as Strategic Advisor
Following momentum from its Crowdcube campaign and investment from EMOTIV, MYndspan is deepening its commitment to evidence-based brain health LONDON,...
PrimeBiome— How PrimeBiome Gummies Boost Glowing Skin With Bacillus Coagulans & Babchi
Clinically-Inspired Supplement PrimeBiome Gains Momentum in 2025 as Consumers Report Radiant Skin, Improved Gut Health, and Healthy Weight Management—All Backed...
Lipozem Reviews (BUYER ALERT!) Is It Legit And Safe To Use? Consumer Report On Reddit Breaks It Down!
MIAMI, April 12, 2025 (GLOBE NEWSWIRE) -- The Lipozem weight loss supplement has been garnering attention in the weight loss...
Weekly Recap: 15 Health Press Releases You Need to See
A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including Google Cloud's commitment to AI-powered...
Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting
– Clinically Meaningful Efficacy Observed on Multiple Assessments – – Confirmed Target Engagement with Reduced Iron Signal in MSA Affected...
ALS Association Partners with Schoox to Enhance Learning for Healthcare Providers, Caregivers, and People Living With ALS
Schoox will deliver access to educational resources, programs, certification courses, and more. AUSTIN, Texas, April 9, 2025 /PRNewswire/ -- Schoox, a...